Clinical Trial - Single Application Brachytherapy – Cervical Cancer

The study run by Tata Memorial Hospital is to evaluate safety and feasibility of single brachytherapy application with dose delivery in multiple fractions. Brachytherapy for cervical cancers has evolved a long way. This study will be conducted in Phase I/II clinical trial setting with strict Image guidance protocol. In the study, researchers expect to reduce treatment duration and increase ease and acceptability of brachytherapy in patients along with significant saving of resources.

The intervention/treatment is radiation – single application multi-fraction brachytherapy.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Intervention Model: Single Group Assignment
Intervention Model Description: Phase I/ Phase II single arm study
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Feasibility and Safety Study of Single Application Multi-fractionated High Dose Rate (HDR) Brachytherapy in Locally Advanced Cervical Cancer
Actual Study Start Date : September 17, 2017
Estimated Primary Completion Date : April 17, 2018
Estimated Study Completion Date : April 17, 2019

For enrollment please visit


Umesh Mahantshetty, MD, DNB      022 24177000 ext 7168       [email protected]

Umesh Mahantshetty, MD, DNB    +91 2224177000 ext 7168    [email protected]

Reference code: NCT03110497

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.